Can the Risk for AMD be Modulated?
Condition(s):Age-Related Macular Degeneration (ARMD)Last Updated:February 2, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Age-Related Macular Degeneration (ARMD)Last Updated:February 2, 2024Recruiting
Condition(s):Age Related Macular Degeneration; Geographic Atrophy; AMD; Age-related Macular DegenerationLast Updated:February 9, 2024Recruiting
Condition(s):Age Related Macular Degeneration; Intermediate AMD; Atrophy; PredictionLast Updated:January 24, 2024Recruiting
Condition(s):Macular DegenerationLast Updated:February 12, 2024Withdrawn
Condition(s):Age-Related Macular DegenerationLast Updated:August 29, 2023Recruiting
Condition(s):Lupus Erythematosus; Lupus Erythematosus, Systemic; Age Related Macular DegenerationLast Updated:May 24, 2021Completed
Condition(s):Age Related Macular DegenerationLast Updated:April 28, 2021Unknown status
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:February 6, 2024Completed
Condition(s):Age-related Macular Degeneration (AMD)Last Updated:January 8, 2024Not yet recruiting
Condition(s):Age-related Macular Degeneration; Vitamin D DeficiencyLast Updated:July 22, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.